The effects of flosequinan on endothelin-1-induced changes in inositol 1,4,5-trisphosphate levels and protein kinase C activity in rat aorta
- 1 July 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 226 (3) , 259-264
- https://doi.org/10.1016/0922-4106(92)90070-c
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Endothelium‐derived relaxing factor inhibits the endothelin‐1‐induced increase in protein kinase C activity in rat aortaBritish Journal of Pharmacology, 1991
- Flosequinan, a vasodilator with a novel mechanism of actionBritish Journal of Pharmacology, 1991
- Inhibition of inositol 1,4,5‐trisphosphate formation by cyclic GMP in cultured aortic endothelial cells of the pigBritish Journal of Pharmacology, 1991
- Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells.Journal of Biological Chemistry, 1990
- Endothelium-derived relaxing factor inhibits the formation of inositol trisphosphate by rabbit aorta.The Journal of Physiology, 1989
- Endothelium‐derived relaxing factor and nitroprusside compared in noradrenaline‐ and K+‐contracted rabbit and rat aortae.The Journal of Physiology, 1988
- Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and catsBritish Journal of Pharmacology, 1988
- Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failureAmerican Heart Journal, 1987
- Activation of protein kinase C by Triton X-100 mixed micelles containing diacylglycerol and phosphatidylserine.Journal of Biological Chemistry, 1985